A Study to Examine Anktiva for the Treatment of COVID-19.

Clinical trial NCT07123727 · RECRUITING

Trial details

NCT number: NCT07123727
Sponsor: ImmunityBio, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Long COVID Long COVID Syndrome Long Covid 19

Start date: 2025-09-04
Primary completion: 2026-07-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.